Weissbach; Herbert
Patent Applications and Registrations
Patent applications and USPTO patent grants for Weissbach; Herbert.The latest application filed is for "derivatives of sulindac can protect normal cells against oxidative damage".
- Weissbach; Herbert - Boynton Beach FL
- Weissbach; Herbert - Boyton Beach FL
- Weissbach; Herbert - Cedar Grove NJ
| Patent | Date |
|---|---|
| Derivatives Of Sulindac Can Protect Normal Cells Against Oxidative Damage App 20220106250 - Piazza; Gary ; et al. | 2022-04-07 |
| Derivatives of sulindac can protect normal cells against oxidative damage Grant 11,186,534 - Piazza , et al. November 30, 2 | 2021-11-30 |
| Retinopathy treatment Grant 10,792,260 - Blanks , et al. October 6, 2 | 2020-10-06 |
| Derivatives Of Sulindac Can Protect Normal Cells Against Oxidative Damage App 20200095184 - Piazza; Gary ; et al. | 2020-03-26 |
| Use Of Sulindac For Protecting Retinal Pigment Epithelial Cells Against Oxidative Stress App 20170143653 - Prentice; Howard M. ; et al. | 2017-05-25 |
| Compositions And Methods For Inducing Differentiation Of Stem Cells App 20160340647 - LOPEZ-TOLEDANO; Miguel ; et al. | 2016-11-24 |
| Retinopathy Treatment App 20160074350 - Blanks; Janet C. ; et al. | 2016-03-17 |
| Protection of normal cells Grant 8,871,971 - Weissbach , et al. October 28, 2 | 2014-10-28 |
| Treatment or prevention of cancer and precancerous disorders Grant 8,765,808 - Weissbach , et al. July 1, 2 | 2014-07-01 |
| Protection Of Normal Cells App 20140018429 - Weissbach; Herbert ; et al. | 2014-01-16 |
| Treatment or prevention of cancer and precancerous disorders Grant 8,603,985 - Weissbach , et al. December 10, 2 | 2013-12-10 |
| Protection of normal cells Grant 8,487,128 - Weissbach , et al. July 16, 2 | 2013-07-16 |
| Treatment or prevention of cancer and precancerous disorders Grant 8,357,720 - Weissbach , et al. January 22, 2 | 2013-01-22 |
| Use Of Sulindac For Protecting Retinal Pigment Epithelial Cells Against Oxidative Stress App 20120295979 - PRENTICE; Howard M. ; et al. | 2012-11-22 |
| Treatment or prevention of cancer and precancerous disorders Grant 8,258,181 - Weissbach , et al. September 4, 2 | 2012-09-04 |
| Treatment Or Prevention Of Cancer And Precancerous Disorders App 20100260864 - Weissbach; Herbert ; et al. | 2010-10-14 |
| Treatment Or Prevention Of Cancer And Precancerous Disorders App 20100069331 - Weissbach; Herbert ; et al. | 2010-03-18 |
| Protection Of Normal Cells App 20090326073 - Weissbach; Herbert ; et al. | 2009-12-31 |
| Protection Against Oxidative Damage in Cells App 20090312238 - Sagher; Daphna ; et al. | 2009-12-17 |
| Catalytic Antioxidants And Methods Of Use App 20090069428 - Weissbach; Herbert ; et al. | 2009-03-12 |
| Catalytic antioxidants and methods of use Grant 7,414,139 - Weissbach , et al. August 19, 2 | 2008-08-19 |
| Treatment Or Prevention Of Cancer And Precancerous Disorders App 20080119559 - WEISSBACH; HERBERT ; et al. | 2008-05-22 |
| Catalytic antioxidants and methods of use App 20070072935 - Weissbach; Herbert ; et al. | 2007-03-29 |
| Catalytic antioxidants and methods of use Grant 7,129,374 - Weissbach , et al. October 31, 2 | 2006-10-31 |
| Treatment or prevention of cancer and precancerous disorders App 20060235080 - Weissbach; Herbert ; et al. | 2006-10-19 |
| Catalytic antioxidants and methods of use App 20040143016 - Weissbach, Herbert ; et al. | 2004-07-22 |
| Method of detecting ribosomal protein antibodies in systemic lupus erythematosus Grant 4,865,970 - Brot , et al. September 12, 1 | 1989-09-12 |
| SEC | 0001218823 | WEISSBACH HERBERT |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 